跳至主要内容
临床试验/NCT03767296
NCT03767296已完成4 期

Influence of a Bolus Administration of Ephedrine and Phenylephrine on the Spinal Oxygen Saturation, Measured With NIRS.

University Hospital, Ghent1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2017年2月6日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
33
试验地点
1
主要终点
Spinal oxygen saturation measured by NIRS

研究概览

简要总结

To evaluate the influence of vasoactive medication on the spinal vasculature, we have chosen patients scheduled for arterial dilation of the lower limb as our study population. In these patients the spinal cord perfusion is not compromised. However, most patients will suffer from hypotension during surgery, due to the non-invasive type of surgery and the vasodilating effects of the anesthetics. Therefore, bolus administration of vasoactive medication (ephedrine, phenylephrine) is routinely required in order to increase the blood pressure.

The aim of the study is to observe the influence of a bolus administration of ephedrine and phenylephrine on the spinal vasculature, measured by NIRS.

详细描述

During the preoperative visit, baseline MAP (mean arterial blood pressure) will be defined.

All patients receive standard anesthesia care during the surgical procedure. Before induction of anesthesia, 6 additional sensors (stickers) are applied to the back of the patient (at three levels: 2 at the upper thoracic level, 2 at the lower thoracic level and 2 at the lumbar region). 2 sensors are routinely applied to the forehead to measure the cerebral oxygenation and a BIS sensor is applied to measure the depth of anesthesia. Through an intravenous line anesthetics will be administered. Vasopressor agents will be administered through a second intravenous line. After induction of anesthesia, an endotracheal tube is placed. According to the estimated duration of surgery a bladder catheter is placed.

If - after induction of anesthesia- MAP has decreased more than 20%, a vasopressor agent will be administered in order to increase the blood pressure to normal (preoperative) values. According to the MAP, several bolus administrations and incremental bolus dosages might be needed to reach the target blood pressure range (MAP decrease less than 20%). According to the group to which the patient has been randomized, a bolus of ephedrine and/or phenylephrine will be administered.

The study will be completed when MAP decreases more than 20% from baseline for the 4th time.

A total amount of Ephedrine and Phenylephrine resp. of 140 mg and 1500 μg will not be exceeded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients > 18y
  • scheduled for dilation of arterial blood vessels of the lower limb

排除标准

  • Age < 18y
  • BMI > 30
  • severe valvular disease
  • previous aortic surgery
  • paraplegia/ paraparesis
  • renal replacement therapy

研究组 & 干预措施

Dose Bolus of E-P-E

Experimental

Ephedrine Hydrochloride 3 MG/ML- Phenylephrine - Ephedrine Hydrochloride 3 MG/ML

干预措施: Ephedrine Hydrochloride 3 MG/ML (Drug)

Dose Bolus of E-P-E

Experimental

Ephedrine Hydrochloride 3 MG/ML- Phenylephrine - Ephedrine Hydrochloride 3 MG/ML

干预措施: Phenylephrine (Drug)

Dose Bolus P-E-P

Experimental

Phenylephrine- Ephedrine Hydrochloride 3 MG/ML - Phenylephrine

干预措施: Ephedrine Hydrochloride 3 MG/ML (Drug)

Dose Bolus P-E-P

Experimental

Phenylephrine- Ephedrine Hydrochloride 3 MG/ML - Phenylephrine

干预措施: Phenylephrine (Drug)

Dose Bolus E-E-E

Experimental

Ephedrine Hydrochloride 3 MG/ML- Ephedrine Hydrochloride 3 MG/ML - Ephedrine Hydrochloride 3 MG/ML

干预措施: Ephedrine Hydrochloride 3 MG/ML (Drug)

Dose Bolus P-P-P

Experimental

Phenylephrine-Phenylephrine-Phenylephrine

干预措施: Phenylephrine (Drug)

结局指标

主要结局

Spinal oxygen saturation measured by NIRS

时间窗: from first till 4th MAP decrease > 20 % from baseline

Spinal oxygen saturation measured by NIRS

次要结局

  • Total amount of vasoactive medication used(from first till 4th MAP decrease > 20 % from baseline)
  • Heart rate(from first till 4th MAP decrease > 20 % from baseline)
  • Blood pressure(from first till 4th MAP decrease > 20 % from baseline)
  • Cerebral oxygenation (NIRS)(from first till 4th MAP decrease > 20 % from baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验